Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia

Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphate...

Full description

Saved in:
Bibliographic Details
Published inNutrients Vol. 12; no. 11; p. 3289
Main Authors Palafox-Serdán, Frida, Luna-Montiel, Olinto A, Pablo-Franco, Sebastián E, Guillen-Tejada, Daniela L, Carreño-Vázquez, Sandra D, Silva Pereira, Taísa S, Islas Romero, Laura M, Villaseñor López, Karen, Ortega-Régules, Ana E, Jiménez-Garduño, Aura M
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 27.10.2020
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country.
Bibliography:These authors contributed equally to the work.
ISSN:2072-6643
2072-6643
DOI:10.3390/nu12113289